ISIS-PTP1BRx

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISIS-PTP1BRx, covering 2015-03-03 to 2015-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes [Phase 2]